[1P-0577] Foxp3のコファクターとしてのPRMT5の同定と、癌免疫療法への応用

〇永井 康裕¹、Mei Q. Ji¹、Yan Xiao¹、Bin Li²、Hongtao Zhang¹、Takuya Ohtani³、Mark I. Greene¹ (1.Dept. of Path. and Lab. Med., Univ. of Penn.、2.Key Lab. of Mol. Vir. and Immu., Chi. Acad. of Sci.、3.Penn inst. of Immu., Univ. of Penn.)

Cancer Immunotherapy, regulatory T cells, Post-translational modification